Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Advisory Committees

Circulatory System Devices Panel Meeting Summary - May 29, 2003

A meeting of the Circulatory System Devices Panel was held on May 29, 2003. The Panel discussed, made recommendations, and voted on a premarket approval application (P020039) for the Cardima® Revelation Tx Microcatheter with NavAblator RF Ablation System.

The device is indicated for treatment of Atrial Fibrillation in patients with drug refractory paroxysmal atrial fibrillation by mapping, pacing, and ablating with a set of continuous linear lesions in the right atrium.

Following presentations by the sponsor and the FDA, and after questioning the sponsor and deliberating, the Panel voted (7-0) that the application be found ‘not approvable’. The Panel cited concerns with primary data endpoints, inconsistent collection of data, and quantity of data obtained for the primary and key secondary endpoints.

Contact: Geretta Wood, Executive Secretary,
(301) 443-8320, ext. 143; gpw@cdrh.fda.gov

Transcripts may be purchased from: (written requests only)
Neal R. Gross & Company
1323 Rhode Island Ave., NW
Washington, DC 20005
(202) 234-4433 (voice), (202) 387-7330 (fax)

Or

Food and Drug Administration
Freedom of Information Staff (FOI)
5600 Fishers Lane, HFI-35
Rockville, MD 20851
(301) 827-6500 (voice), (301) 443-1726 (fax)

Under normal circumstances, panel summary minutes are available 60-90 days post meeting. Summaries are also available on the CDRH web site.

Page Last Updated: 08/05/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.